From discoveries to inventions

Dimension Biotechnologies is addressing unmet global vascular health challenges by improving diagnostic tools. Its transformative technology non-invasively monitors microscopic blood vessels at the biochemical level enabling doctors, drug developers and scientists to rapidly assess microvascular health and disease.

GenomeKey is transforming how healthcare clinicians diagnose and treat infections like sepsis to improve patient outcomes. Using cutting-edge machine learning and DNA sequencing, the company is developing a next-generation diagnostic device to identify bacterial genomes and determine their antimicrobial susceptibility directly from patient blood in just a few hours, rather than days. This enables clinicians to prescribe the right antibiotics for patients with much more efficiency and accuracy, reducing costs, minimising unnecessary antibiotic use and ultimately saving millions of lives from the world’s leading cause of death.

Native Labs is transforming bioprocesses for cellular innovations with its manufacturing technology. By applying its intelligent operating system, Native Labs harnesses state-of-the-art, neural network-based models to accelerate predictions, enable precise control and release products confidently through real-time quality verification. This approach offers a cost-effective, time-efficient manufacturing alternative for bioprocesses, from regenerative medicine to cultivated protein.